Sign inGet started

Resnick Joshua

Insider CIK 1690959 · KALV Director · CDTX Director · AVTE Director · VOR Director · PEPG Director · SION Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PEPG PepGen Inc. A Award deriv2026-06-182026-06-2234,000— $034,000SEC↗
SION Sionna Therapeutics, Inc. A Award deriv2026-06-172026-06-1817,340— $017,340SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-075,079— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-0722,200— $00SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2025-06-182025-06-185,079— $05,079SEC↗
SION Sionna Therapeutics, Inc. A Award deriv2025-06-122025-06-1619,959— $019,959SEC↗
PEPG PepGen Inc. A Award deriv2025-06-042025-06-0616,000— $016,000SEC↗
VOR Vor Biopharma Inc. A Award deriv2025-05-222025-05-2330,000— $030,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2025-01-032025-01-0722,200— $022,200SEC↗
PEPG PepGen Inc. A Award deriv2024-06-202024-06-2113,000— $013,000SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2024-06-052024-06-0712,500— $012,500SEC↗
VOR Vor Biopharma Inc. A Award deriv2024-05-232024-05-2830,000— $030,000SEC↗
PEPG PepGen Inc. A Award deriv2023-06-222023-06-2612,000— $012,000SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2023-06-062023-06-0812,500— $012,500SEC↗
VOR Vor Biopharma Inc. A Award deriv2023-05-262023-06-0230,000— $030,000SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2022-06-212022-06-2212,500— $012,500SEC↗
VOR Vor Biopharma Inc. A Award deriv2022-06-142022-06-1616,911— $016,911SEC↗
PEPG PepGen Inc. A Award deriv2022-05-062022-05-1011,667— $011,667SEC↗
AVTE Aerovate Therapeutics, Inc A Award deriv2021-06-292021-07-0125,000— $025,000SEC↗
VOR Vor Biopharma Inc. A Award deriv2021-02-052021-02-0916,900— $016,900SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2017-09-272017-09-296,000— $06,000SEC↗
KALV KalVista Pharmaceuticals, A Award deriv2017-03-232017-03-2712,000— $012,000SEC↗
KALV KalVista Pharmaceuticals, A Award2016-11-212016-11-292,508,279— $02,508,279SEC↗
KALV KalVista Pharmaceuticals, A Award2016-11-212016-11-2971,211— $071,211SEC↗